Please, register First.

In order to access this section it is necessary to register first in the members area!

Thank you

An email has been sent.
Unable to send email.
Please verify the email adrress.

SIGN IN

Please, in order to enter to the members area fill in the boxes below this lines.

LOGIN:
PASSWORD:
  enter to members area
  Forgot your password?

Please type your email address below and you will shortly receive an email.

EMAIL:
  send email
  Cancel

OUR PARTNERS

he upgrading of the research and innovation capacities and capabilities of AIMEN in the planned Strategic Research Fields (SRFs) will be supported by the collaboration of the following European Research Centers of Excellence

AIMEN Technology Centre

The Technology Centre AIMEN is a non-profit private association that provides industry with R&D and services in all areas of metallurgy, materials technology, manufacturing processes, testing and inspection. Over 210 skilled staff is dedicated to improve manufacturing processes in the industry and increase their level of competitiveness. The Technology Centre AIMEN participates in numerous regional, national and international R&D&i and technology transfer activities, in most cases in collaboration with the industry, both SMEs and large multinational companies that can be grouped into the following five research lines: Joining Technologies, Laser Technologies, Materials and Manufacturing Processes, Design and Simulation, and Non Destructive Testing.

Fraunhofer Institute for Machine Tools and Forming Technology (FhIWU)

The Fraunhofer Institute for Machine Tools and Forming Technology IWU is part of the Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V., Europe’s largest organization for applied research. The institute itself is one of the most renowned research institutes for industrially-led production technology in Germany. The development of intelligent production devices and the optimization of its related manufacturing processes are the institute’s main research focuss.

The Department Precision Technology and Micromanufacturing’s engineering expertise includes precision machining of micro- and macrocomponents and technologies for adjusting surface properties of metallic and non-metallic materials.

Applied Functional Materials Ltd (AFM)

Applied Functional Materials Ltd (AFM) was established in 2004 as a spin Birmingham, to develop components for ultrasound devices using micro micro-scale ceramic manufacturing techniques.. The company possesses a platform of novel ceramic processing technologies which enable themanufacture of unique functional ceramic devices in complex shapes and micro several years developing its own product set. The first iteration of this technology (a high element transducer) has now been technically proven and patent protected and is generating significant interest from end users in the medical imaging market. Over the last 18 months, the company has successfully engaged with component manufacturers and OEMs operating in a $5bn market, and has established a strong pipeline of potential customers. AFM is in the final stages of raising investment capital of £400k to take it’s initial medical imaging devices to market.

Adama Innovations Ltd (ADAMA)

Adama Innovations is a start-up company commercialising a novel nano-patterning technology developed at CRANN, the nano-technology institute based in TCD. Initially demonstrated on diamond, this proprietary high resolution patterning technology provides a flexible, simple, cost-efficient method to add nano-scale structures to a variety of materials. The first commercial products of the technology include diamond-based high performance metrology probes. Applications range from MEMS, semiconductor and hard disk drive manufacturing, to LED photonics. The technology is also deployed in nano-pattern imprinting, for the production of long lifetime dies for both roll-to-roll and flat stamping operations. This high precision, high volume manufacturing technique lends itself to a variety of industrial applications such as patterning biomedical implants; anti-counterfeit, holographic or decorative images in metal surfaces; micro optical components in glass or polymers.

SensLab Gesellschaft zur Entwicklung und Herstellung bioelektrochemischer Sensoren mbH (SensLab)

During the first years of its existence SensLab developed a range of reusable enzyme sensors for food analysis and monitoring biotechnological processes. In the year 2002 SensLab changed the product portfolio and focused its activities to the development of disposable enzyme test strips for POC / home care diagnostics.Important aspects of SensLab’s core sensor technology have been patented in Germany, Europe, and USA.

The company possesses production facilities for screen printing of test strips, microdispensing of liquids, and assembling test strips. The laboratories are well equipped by instruments for electrochemical methods, spectrophotometric experiments and by other analytical devices for characterization of protein preparations, surface geometries and microfluidic arrangements. Microfluidic lactate test strips for blood lactate measurements developed by SensLab have been introduced successfully to the diagnostic market at 2003 presenting the most important selling product of SensLab in the mean time.

Core technologies of SensLab are: (i) disposable sensor technology for POC-T, (ii) enzyme immobilization techniques for sensor applications, (iii) the design of electron transfer pathways by redox mediators, (vi) -structuring of microfluidic arrangements in polymeric foils , (v) polymeric thick-film technology for the manufacture of planar structured voltammetric sensors, (vi) affinity sensors based on electrochemical/enzymatic signal amplification, and (vii) fuzzy logic and HMM processing of voltammetric (bio)sensor signals.

The company has been certificated according to DIN EN ISO 13485:2003 (successful re-audit 03-04-2012).

Universidade de Aveiro (UAVR)

University of Aveiro (UAVR) was created in 1973 by Government Decree and, in 2009, became a public foundation operating under private law. UAVR is one of the most dynamic and innovative universities in the country, with more than 15.000 students distributed for 231 undergraduate, postgraduate and post-secondary courses. UAVR is also a place for research, where innovative products and solutions are developed to contribute to the advance of science and technology. It is a privileged partner for companies and other national and international organisations with which the University cooperates in numerous projects and for which it provides important services. Centre for Research in Ceramics and Composite Materials(CICECO) is an associated lab in UAVR and is the largest Portuguese institute in the field of materials science and engineering, which lines of expertise are Nano- and Micro-Structured Materials; Materials for Energy and Industrial Applications; Sustainability and Biomaterials.

Instituto de Engenharia Mecânica e Gestão Industrial (INEGI)

INEGI is an interface Institution between University and Industry, oriented to the activities of Research and Development, Innovation and Technology Transfer. It was founded in 1986, among the Department of Mechanical Engineering and Industrial Management of the Faculty of Engineering of the University of Porto. Being a non-profit private association and recognized as being of public utility, INEGI is currently considered an active agent playing a significant role in the development of the Portuguese industry, and in the transformation of its competitive model.

It is our mission to contribute for improving the competitiveness of the economy and the social welfare, through technology-based innovation applied to processes, products and business models, as well as the development of R&D, technology transfer and innovation management best-practices.

Our core competences are in the fields of mechanical engineering, engineering design, materials, industrial processes, renewable energies and environment, and industrial engineering and management.

Our action is focused on providing added-value services to our clients and partners. Our capability to add value to our clients is grounded on our large experience of working with companies, our permanent drive to understand their needs and our innovation projects implementation practices, always with a result oriented mind set.

Research Center for Non Destructive Testing GmbH (RECENDT)

The company is a 2009 – spin-off from the Upper Austrian Research (UAR) where the technological expertise has been built up since the year 2000. Shareholders are still the UAR, the Johannes Kepler University Linz (JKU) and the Upper Austrian University of Applied Science (FH OOE).

RECENDT has earned the honour of being nominated as the only non-university-based Christian Doppler Laboratory (CD-Lab) in Austria. For their scientific work the Researchers have been awarded the special price for research-facilities at the Upper Austrian “Innovationspreis 2010”.

The activities comprise the whole R&D process chain from application-oriented fundamental research up to the development of novel instrument technologies for industrial application. Novel technologies that seem promising for a future industrial application are driven forward in fundamental research until the point where RECENDT takes the step towards development of prototypes suited for industrial needs.

At the moment the researchers are dealing with the technological fields of optical coherence tomography (OCT), infrared spectroscopy (IR), THz technology (THz), laser ultrasound (LUS), and photoacoustic imaging (PAI).

The interdisciplinary, highly qualified team consisting of physicists, chemists, mechatronic and development engineers has state-of-the-art equipment at its disposal in order to effectively apply its competences to contribute to the success of local companies.

Promolding BV (PROMOLD)

Promolding BV is an innovative company that transforms high-performance polymer technology into industrialized applications. Promolding offers its customers the whole sequence from product design, via (new) materials and process development, to manufacturing, including automation. Promolding is very active in the use of new and high-tech materials such as biodegradable materials and technical plastics with additional functionalities such as electrical conductivity and heat conductivity, as well as new mould en production technologies.

Promolding focuses on markets for high performance applications such as aircraft industry, medical devices industry, special-machine building, sensor technology and the electronics industry. In these markets there is always a strong demand for new materials with higher stiffness and strength and additional functionalities such as EMI shielding, antistatic behaviour, wear resistance, low permeability and heat dissipation.

During the last 13 years Promolding has worked (and still works) together in many national and EU-funded research programmes, such as Ecobinders, PolyCond, Micromilling, Hipermoulding, Contact, Bugworkers, Esprit, Sonoplast and Sonorus.

CROSPON LIMITED (CROSPON)

Crospon is a medical device company based in Galway, Ireland. The company was established in 2006 and has 15 employees.

Crospon has technology in development which is based on IP assigned from HP Labs using inkjet printing technology in order to develop a drug delivery platform that enables painless, controlled release of one or more drugs in a single patch applied to the skin. The drug delivery platform will be based on an array of drug filled wells, each well being linked to an individual microneedle. A microprocessor based control system will be able to activate each one of the wells individually using a micro-heater, forcing liquid drug formulation through themicroneedle through the stratum corneum (outer layer of the skin) and into the dermis. The propulsionmechanism is based on an expansion material which undergoes a radical increase in volume as its temperature passes through a critical temperature.

The team members on this project have a well established track record in introducing novel electro-medical devices to the market. The development of hollow microneedles is a critical aspect to the Crospon drug deliverypatch.

TWOPTICS SYSTEMS DESIGN, S.L (TSD)

TWOPTICS SYSTEMS DESIGN provides optical engineering talent for world-class optical systems. We create applied engineering solutions for a wide range of applications. Our focus is on innovative, cost-effective designs. We enjoy solving problems with creativity and collaboration. Our highly skilled engineers bring extensive experience and knowledge of both theoretical and applied systems. Based in Barcelona, Spain, our team has the expertise to tackle the most complex of challenges.

TWOPTICS does engineering business in Europe as ASE Optics Europe, due to the joint venture agreement with RPO and ASE Optics, from Rochester, NY, to fully provide customers the possibility of moving from lens and assembly design to prototype to full production if needed. The accumulated experience of TWOPTICS and ASE in engineering adds differential value to the development of optical systems.

Accumulated expertise covers optical design and engineering, optical systems design, metrology, prototype assembly in precision optics for imaging and non-imaging systems.

Servizo Galego de Saúde, (SERGAS)

The “Servicio Galego de Saude” (SERGAS) is an autonomous administrative body responsible for the management and provision of health services in the Public National Health Care system in the Region of Galicia (Population: 2.772.533). It includes a network of 14 hospitals, 3 of them university hospitals, 457 primary health care centers and more than 37.000 workers (7314 physicians). Biomedical research and development is one of the most important activities in the SERGAS.

Ramón Dominguez Foundation is the non-for-profit entity in charge of the management of the research carried out in the main Hospital in Galicia, the University Hospital of Santiago de Compostela. The Ramón Dominguez Foundation manages at present more than 90 research projects funded through competitive calls, more that 400 clinical trials as well as numerous collaborations with industry”.